Authorization

GMO algae: a future raw material for industry

The algae that live in rivers and the sea have been the focus of a great deal of attention in recent years. Whether micro, macro, green, brown, red… they are currently at the heart of an industrial development project for which the European Commission is active. These GMO algae could be deregulated if the European Commission’s July 2023 proposal were to be approved, as they will undergo genetic modification to be transformed into production facilities for pharmaceuticals, cosmetics, food and agrofuels. This article is a first dive into a world that has gone unnoticed until now.

Polish proposal on patents and GMOs casts doubts among Member States

In January 2025, Poland, president of the Council of Europe, put a proposal on the table of EU member states to “solve” the patent problem that had arisen in the debate on deregulating GMOs obtained by new techniques. Complex and of uncertain effectiveness, the Polish proposal has plunged everyone into doubt. Discussions on this text may therefore not be concluded before Denmark, whose government supports total deregulation of GMOs, takes over the presidency of the European Union.

Through its silence, the European Commission has been keeping Mon810 maize authorised since 15 years

Mon810 maize is the only transgenic GM plant authorized for commercial cultivation in the European Union. This authorization was initially granted, via France, almost 30 years ago, in 1998, for an initial period of 10 years. A renewal application was submitted in 2007. Since then, no decision has been taken by the European authorities. How this maize, which authorization theoretically expired in 2008, can still be grown legally in Europe? Simply because European law accepts that, as long as the European Commission has not responded to a request for renewal, the initial authorization remains valid. To date, it’s been 15 years that the Commission fails to respond to Bayer/Monsanto’s request.

Fungicide and herbicide micropeptides on Europe’s doorstep?

Toulouse-based Micropep Technologies has just had one of its fungicidal micropeptides approved in the United States. The technology, developed and patented by this CNRS spin-off, is aiming for European approval by 2030. However, these micropeptides are raising questions about their potential impact on ecosystems.

GMO plants, bacteria, viruses and animals: can they all be deregulated?

Genetically modified microorganisms to be released soon in the EU environment ?

EU: vitamins and additives produced by GMOs

Journal

GMO: In the USA, a decade of promises without commercialization

The European Commission wants to put an end to GMOs

GMO micro-organisms: discreet production factories

GMO pigs: sausages for offspring selection

EFSA: independence and transparency to be improved